RLS, an isotope producer and provider of services to the nuclear medicine market, agreed to acquire the Radiopharmacy Network from General Electric, an American multinational conglomerate. Financial terms were not disclosed. “I was intrigued and excited about the possibilities of this healthcare acquisition, beyond the financial aspects of the transaction. I have spent my career providing white-glove investment advisory services to global clients and always believed that customers, no matter the industry, not only deserve, but have a right to demand personalized, timely, high-end service, that is why we focus on service, quality and disruptive technology as key factors in our investment strategy,” Werner Gruner, RLS Chief Executive Officer.